PXR ablation alleviates steatohepatitis in high-fat diet-induced obesity mice and genetic obesity model ob/ob mice, suggesting the therapeutic potential of PXR antagonists in NAFLD [223]. The gene discussed is NR1I2; the disease is obesity due to melanocortin 4 receptor deficiency.